会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NEW PSYCHOSTIMULANT AGENT
    • 新的PSYCHOSTIMULANT代理
    • WO1988002254A1
    • 1988-04-07
    • PCT/HU1987000040
    • 1987-09-25
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RTKNOLL, JózsefSIMAY, AntalSZINNYEI, ÉvaSOMFAI, ÉvaTÖRÖK, ZoltánMOZSOLITS, KárolyBERGMANN, János
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RT
    • A61K31/135
    • A61K31/135
    • Pharmaceutical composition comprising as active ingredient a compound of general Formula (I), wherein R stands for straight or branched chain alkyl comprising 1 to 8 carbon atoms; phenyl alkyl having 7 to 10 carbon atoms; phenyl; or cycloalkyl comprising 3 to 8 carbon atoms; R stands for straight or branched chain alkyl comprising 1 to 8 carbon atoms, alkyl comprising 1 to 8 carbon atoms substituted by halogen, hydroxy, alkoxy having 1 to 4 carbon atoms or by one or two phenyl groups; phenyl; or cycloalkyl having 3 to 8 carbon atoms, with the proviso that groups R and R together contain at least three carbon atoms. The invention also relates to a process for the preparation of compounds of the general Formula (I) by methods known per se. The compounds of the general Formula (I) are psychostimulants having a new spectrum of effect which can be used in therapy for increasing psychical activity (learning and retention) and for treating clinical patterns of depression and deficites of learning and retention like in Alzheimer's disease, and are void of side effects (e.g. due to catecholamine release) of known stimulants.
    • 药物组合物,其包含作为活性成分的通式(I)的化合物,其中R 1代表包含1至8个碳原子的直链或支链烷基; 具有7至10个碳原子的苯基烷基; 苯基; 或包含3至8个碳原子的环烷基; R 2代表包含1至8个碳原子的直链或支链烷基,由卤素,羟基,具有1至4个碳原子的烷氧基或1或2个苯基取代的1至8个碳原子的烷基; 苯基; 或具有3至8个碳原子的环烷基,条件是基团R 1和R 2一起含有至少三个碳原子。 本发明还涉及通过本身已知的方法制备通式(I)的化合物的方法。 通式(I)的化合物是具有新的效应谱系的精神兴奋剂,其可用于治疗增加心理活动(学习和保留)和用于治疗抑郁症的学习和保留的临床模式,如阿尔茨海默病, 并且没有已知的兴奋剂的副作用(例如由于儿茶酚胺释放)。
    • 3. 发明申请
    • IMPROVED PROCESS FOR THE PREPARATION OF AMIDOXIME DERIVATIVES
    • 改进酰胺衍生物的制备方法
    • WO1990008131A1
    • 1990-07-26
    • PCT/HU1990000003
    • 1990-01-10
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RTBERTOK, BélaSZÉKELY, IstvánTHURNER, AngelikaSOMFAI, ÉvaBOTAR, SándorGAJARY, AntalTAKACS, KálmánNAGY, Lajos
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RT
    • C07C251/58
    • C07D213/78C07C259/12C07D295/088
    • The invention relates to an improved process for preparing amidoxime derivatives of general formula (I), wherein R means a C2-15 group, which may be unsaturated and/or cyclic alkyl, aralkyl group or optionally substituted and/or condensed aromatic and/or heteroaromatic group; R stands for hydrogen or an optionally substituted straight or branched chain or cyclic and/or unsaturated C1-7 alkyl or aromatic group; R represents an optionally substituted straight or branched chain or cylic and/or unsaturated C1-7 alkyl or aromatic group; or R and R together with the adjacent nitrogen atom may form a 5- to 8-membered ring optionally containing other heteroatom(s); and X stands for halogen and their salts by reacting an amidoxime of general formula (II), wherein R is as defined above, in the presence of an alkaline substance, transforming the product to a salt with an acid or transforming the salt to the base, which comprises reacting the amidoxime with an alkaline metal hydroxide or alkaline metal alkoxide and dimethylformamide or 1,3-dimethyl-2-imidazolidinone, preferably in the presence of a proton source, reacting the amidoxime complex thus obtained preferably without isolation with an amine of general formula (III). The invention relates further to pure O-(2-hydroxy-piperidino-1-propil)nicotinic acid amidoxime hydrochloride and hydrobromide and O-(2-hydroxy-3-piperidino-1-propyl)nicotinic acid amidoxime base.
    • 本发明涉及一种制备通式(I)的偕胺肟衍生物的改进方法,其中R 1表示C2-15基团,其可以是不饱和和/或环状烷基,芳烷基或任选取代的和/或稠合的芳族 和/或杂芳族基团; R 2代表氢或任选取代的直链或支链或环状和/或不饱和的C 1-7烷基或芳基; R 3表示任选取代的直链或支链或环状和/或不饱和的C 1-7烷基或芳基; 或R 2和R 3与相邻的氮原子一起可以形成任选含有其它杂原子的5-至8-元环; X代表卤素及其盐,通过在碱存在下使通式(II)的偕胺肟(其中R 1如上述定义)在酸存在下反应,将产物转化为酸或转化盐 包括使偕胺肟与碱金属氢氧化物或碱金属醇盐和二甲基甲酰胺或1,3-二甲基-2-咪唑啉酮反应,优选在质子源存在下,使得到的偕胺肟配合物优选不与其分离而与 通式(III)的胺。 本发明还涉及纯O-(2-羟基 - 哌啶子基-1-丙基)烟酸偕胺肟盐酸盐和氢溴酸盐和O-(2-羟基-3-哌啶子基-1-丙基)烟酸偕胺肟碱。
    • 7. 发明申请
    • PROCESS FOR PRODUCING DIACYLDIANE HYDROHEXITES
    • 二氯乙烷水解生产工艺
    • WO1985003293A1
    • 1985-08-01
    • PCT/HU1985000002
    • 1985-01-16
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RTSZABO, TiborVIDRA, LászlónéDALMADI, GyulaKACZMAREK, EdwardnéORI, János
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RT
    • C07D303/16
    • C07D303/16
    • Process for producing compounds having the general formula (I) from hexites having the general formula (II) by acylation with corresponding acid anhydrides, R et R being independent from each other and representing optionally a free carboxyl group, an alkoxycarbonyl group with 2-5 atoms of carbon or a chlorine substituted alkanyl group with 1-6 atoms of carbon, an aryl group with 7-11 atoms of carbon, a cycloalkylcarbonyl group with 7-11 atoms of carbon, a 2-furanyl group or an alkylarylcarbonyl group with 8-11 atoms of carbon, and the configuration of the hexite skeleton is similar to the configuration of dulcite, mannite or idite. The process is characterized in that the acylation is carried out in the presence of catalysts having the general formula (IV), wherein R and R represent independently from each other an alkyl group comprising each 1-6 atoms of carbon or form together an alkylene group with 1-6 atoms of carbon, and can be optionally substituted by one or two dimethylamino groups.
    • 通过用相应的酸酐进行酰化从而生成具有通式(II)的己烷的具有通式(I)的化合物的方法,R 1和R 1彼此独立地表示任选的游离羧基,烷氧基羰基与 2-5个碳原子或具有1-6个碳原子的氯取代的烷基,具有7-11个碳原子的芳基,具有7-11个碳原子的环烷基羰基,2-呋喃基或烷基芳基羰基 具有8-11个碳原子的碳原子,并且六元素骨架的构型类似于dulcite,mannite或idite的构型。 该方法的特征在于酰化反应在具有通式(Ⅳ)的催化剂存在下进行,其中R 2和R 3彼此独立地表示包含每个1-6个碳原子的烷基 或者与1-6个碳原子一起形成亚烷基,并且可以任选被一个或两个二甲基氨基取代。
    • 8. 发明申请
    • LIPOSOME COMPOSITION CONTAINING SELEGILIN
    • 含有塞来吉林的脂肪组合物
    • WO1996012472A1
    • 1996-05-02
    • PCT/HU1995000052
    • 1995-10-20
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RTMEZEI, MichaelGAAL, JózsefSZÉKACS, GáborSZEBENI, GyulaMARMAROSI, TamásnéMAGYAR, KálmánLENGYEL, JózsefSZATMARI, IstvánTURI, Agnes
    • CHINOIN GYOGYSZER ÉS VEGYÉSZETI TERMÉKEK GYARA RT
    • A61K09/127
    • A61K31/137A61K9/127
    • This invention provides liposomic composition, containing as active ingredient (-)-N- alpha -dimethyl-N-(2-propynylphenylethylamine) (selegilin) and/or salt thereof. This composition contains: 0.1-40 % by weight of selegilin and/or a salt thereof, 2 to 40 % by weight of lipids, preferably phospholipids, 0 to 10 % by weight of cholesterol, 0 to 20 % by weight of an alcohol, 0 to 25 % by weight of a glycol, 0 to 3 % by weight of an antioxidant, 0 to 3 % by weight of a preserving agent, 0 to 2 % by weight of a viscosity influencing agent, 0 to 50 % by weight of cyclodextrin or a cyclodextrin derivative and 30 to 90 % by weight of water. This invention relates to pharmaceutical composition, containin the liposomic composition described and if desired, usual filling and diluting agents and other auxiliaries, preferably in oral, parenteral or transdermal form. This invention provides the process for the preparation of liposomic compositions containing selegilin and/or salt thereof. Accordingly liposomic composition of this invention may be administered for the treatment of Alzheimer's disease, Parkinson's disease, depression, stroke, motion sickness or myelitis.
    • 本发明提供含有作为( - ) - N-α-二甲基-N-(2-丙炔基苯乙胺)(selegilin)和/或其盐的活性成分的脂质体组合物。 该组合物包含:0.1-40重量%的赛莱格林和/或其盐,2至40重量%的脂质,优选磷脂,0至10重量%的胆固醇,0至20重量%的醇, 0〜25重量%的二醇,0〜3重量%的抗氧化剂,0〜3重量%的防腐剂,0〜2重量%的粘度影响剂,0〜50重量% 环糊精或环糊精衍生物和30〜90重量%的水。 本发明涉及药物组合物,所述药物组合物包含所述的脂质体组合物,如果需要,含有通常的填充和稀释剂和其它助剂,优选口服,肠胃外或透皮形式。 本发明提供了制备含有塞来林和/或其盐的脂质体组合物的方法。 因此,本发明的脂质体组合物可以用于治疗阿尔茨海默氏病,帕金森病,抑郁症,中风,运动病或脊髓炎。